Market Place
Sourcing Support
Lupin`s Generic Tolvaptan Receives Approval in the U.S.
05 Oct 2023 //
FDA
Alkem`s Generic Tolvaptan Receives Approval in the U.S.
06 Sep 2022 //
FDA
Apotex`s Generic Tolvaptan Receives Approval in the U.S.
06 Sep 2022 //
FDA
Hetero`s Generic Tolvaptan Receives Approval in the U.S.
06 Sep 2022 //
FDA
Palladio Biosciences Announces Presentation of Data from a Study of Lixivaptan
20 Oct 2020 //
BUSINESSWIRE
Apotex`s Generic Tolvaptan Receives Approval in US
23 May 2020 //
FDA
Alkem Lab Generic Tolvaptan Receives Approval in US
23 May 2020 //
FDA
Alkem Lab`s Generic Tolvaptan Receives Tentative Approval in US
31 Jan 2020 //
FDA
Daiichi-Sankyo, Bayer, Otsuka & Others Called Out for UK Advertisement Breaches
12 Aug 2019 //
RAPS
Otsuka Pharmaceutical`s Samsca (tolvaptan) Receives Approval in Europe
12 Oct 2018 //
EMA
EC approves extension of indication for Otsuka’s tolvaptan for CKD
02 Aug 2018 //
BUSINESSWIRE
Samsca® (tolvaptan): Otsuka Pharmaceutical Co., Ltd., v. Alkem Laboratories Ltd.,
29 Jun 2018 //
PATENT LITIGATION
FDA Confirms Paragraph IV Patent Challenge of Samsca (Tolvaptan) Tablets
23 May 2018 //
FDA
Otsuka Announces Ph3 Results for Tolvaptan in Patients with Autosomal Disease
06 Nov 2017 //
BUSINESSWIRE
Otsuka to Host Web Briefing on Tolvaptan Ph3 Trial Results in Polycystic KD
27 Oct 2017 //
BUSINESSWIRE
Otsuka Announces Results of Phase 3 Data on Tolvaptan
22 May 2017 //
BUSINESSWIRE
Six new therapies approved for NHS Scotland
12 Jan 2016 //
PHARMATIMES
Otsuka`s Jinarc (Tolvaptan) Approved in US For Polycystic Kidney Disease
13 Jun 2015 //
EMA
Otsuka`s Jinarc (Tolvaptan) Approved in Canada for ADPKD
28 Feb 2015 //
OTSUKA
Jinarc Recommended for Approval in Rare Kidney Disease
27 Feb 2015 //
EMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.